Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

      November 7, 2025
      Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
      Research & Development

      Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

      July 30, 2025
      Research & Development

      $20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

      July 11, 2025
  • Clinical
    • Clinical

      CagriSema Shows Greater Blood Sugar and Weight Reduction Than Semaglutide in Phase 3 Trial

      February 4, 2026
      Clinical

      Sanofi Reports Divergent Phase III Results for Venglustat in Gaucher and Fabry Diseases

      February 4, 2026
      Clinical

      GSK Returns WVE-006 Rights to Wave Following Phase Ib/IIa AATD Results

      February 4, 2026
      Clinical

      Quince Therapeutics’ Phase 3 eDSP Trial Fails to Meet Endpoints in Ataxia-Telangiectasia

      February 4, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      AstraZeneca commits $15 billion investment in China to advance radioconjugates and cell therapy innovation

      February 4, 2026
      Commercial

      AstraZeneca and CSPC Sign Up to $18.5 Billion Ex-China Weight Management Collaboration

      February 4, 2026
      Commercial

      Eli Lilly Partners With Seamless Therapeutics to Develop Gene Editing Treatments for Hearing Loss

      January 30, 2026
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      Reg impact assessment next in GenAI’s sights, experts claim

      June 26, 2025
      Insights

      The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

      December 1, 2024
      Insights

      Improving life science R&D outcomes with AI

      November 8, 2024
      Insights

      The medical device sector’s surging regulatory burden: how are suppliers coping?

      October 12, 2024
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Fabry disease

Tag: Fabry disease

venglustat
Clinical

Sanofi Reports Divergent Phase III Results for Venglustat in Gaucher and Fabry Diseases

Editorial Team -
February 4, 2026
0

Editor Picks

Myricx Bio Raises $114M in Series A Funding to Advance NMTi-ADCs Development

July 9, 2024

Novartis spinoff Sandoz to establish HQ in Basel

June 6, 2023

Sellas Leukaemia trial yields promising results

November 22, 2022

Must Read

CagriSema Shows Greater Blood Sugar and Weight Reduction Than Semaglutide in Phase 3 Trial

February 4, 2026

Sanofi Reports Divergent Phase III Results for Venglustat in Gaucher and Fabry Diseases

February 4, 2026

GSK Returns WVE-006 Rights to Wave Following Phase Ib/IIa AATD Results

February 4, 2026

Hot Topics

  • Clinical389
  • Commercial364
  • Regulatory303
  • Research & Development102
  • Manufacturing79
  • Newsletter59
  • Technology40
  • News31
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial